PLEASANTON, Calif. — Roche (SIX: RO, ROG; OTCQX: RHHBY) has signed a definitive asset purchase agreement with Lumora for products associated with the unique, patent-protected Heat Elution1technology for nucleic acid purification of multiple sample types including challenging formalin-fixed paraffin-embedded (FFPE) tumor samples. Roche plans to explore integrating this technology into its sequencing workflow solution. Today, […]
Cambridgeshire, UK — Lumora, a provider of state-of-the-art molecular diagnostic products for the clinical research and industrial markets, has sold its proprietary nucleic acid Heat Elution purification technology1 to Roche. Roche has signed a definitive Asset Purchase Agreement with Lumora for products associated with its proprietary nucleic acid Heat Elution purification technology that is designed […]
Madrid, Spain and Heidelberg, Germany – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced that it has signed a distribution agreement with Nanodigmbio Co. Ltd. for the commercialization of SYGNIS’ proprietary product portfolio in China. China is set to become a crucial player in the healthcare and life sciences industry and is expected […]
SAN DIEGO — Cypher Genomics, Inc., the leading genome informatics company, in partnership with the Rare Genomics Institute, today announced winners in the 2015 BeHEARD Challenge. BeHEARD is a global competition that funds projects submitted by researchers studying rare diseases or individuals affected by them, awarding them with technology prizes that will facilitate their projects. […]
ST LOUIS, MO – Appistry, Inc., a leading provider of software and services that enable healthcare institutions to practice genomically enhanced medicine, announced today the availability of GenomePilot on Microsoft’s Azure Marketplace. Through a new collaboration, Appistry will actively participate with Microsoft and other partners in the development of a complete set of cloud-based services […]
COLUMBUS, Ohio — Battelle’s revolutionary new software, ExactID®, will be engaged by investigators at the U.S. Defense Forensic Science Center under a new agreement. ExactID is the first commercial forensic genomics software system that lets forensic investigators harvest the power of next-generation sequencing data in a format suited for routine laboratory analysis. ExactID provides the […]
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it has signed a definitive agreement to acquire Kapa Biosystems, Inc. (Kapa) a privately-held company headquartered in Wilmington, Massachusetts, US. Kapa Biosystems is a provider of genomic tools in the life sciences sector that employs proprietary technologies to optimize enzymes for next-generation sequencing (NGS), as well as […]
SAN FRANCISCO — Illumina, Inc. (NASDAQ: ILMN), Warburg Pincus and Sutter Hill Ventures announced today that they have formed a company to empower consumers to discover insights into their own genomes through a vibrant ecosystem of high-quality content partners. The company, called Helix, is based in the San Francisco Bay Area and received financing commitments […]
BETHESDA, MD – The ACMG Foundation for Genetic and Genomic Medicine (www.acmgfoundation.org) recently announced that four new directors have been elected to join its Board of Directors. The ACMG Foundation is a national nonprofit foundation dedicated to facilitating the integration of genetics and genomics into medical practice. The board members are active participants in serving […]
BOULDER, Colo.– ArcherDX launched Archer™ PreSeq™ QC Assays, which assess the quality of nucleic acid in FFPE samples prior to library creation for next-generation sequencing (NGS)-based mutation detection. “NGS is an extremely effective way to find oncogenic driver mutations in a tumor specimen, but analytical sensitivity and specificity are dependent upon the quality of the […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
